Hemispherx Biopharma (HEB)

0.27 -0.00  -0.99%  May 25, 11:00PM Go Pro
Watch this stock
View Full Chart HEB Price Chart

Key Stats

Market Cap 36.67M
Revenue Growth 40.74%
Profit Margin -8197%
Earnings Yield -25.93%
Dividend Yield 0.00%
Earnings Per Share TTM -0.07
PE Ratio
Price / Sales Ratio 227.35
52 Week High 0.51
52 Week Low 0.173
Beta 1.216
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 22 $HEB just checking..woof by roadkingtrdr
May 10 $HEB it can only go to $0 .right? what a joke by roadkingtrdr
May 07 $HEB maybe Carter can put Ampligen in e-cigarettes now that it's 2012 since he already explored putting it in real cigarettes in the 1980's by HankHill
May 07 Hemispherx Biopharma (HEB) Doubles Q Loss to 2c/Share Street Insider
May 07 Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31,...
May 07 $HEB filed latest Quarterly Report http://stks.co/3hv0 by MarketBrief
May 07 HEMISPHERX BIOPHARMA INC Files SEC form 10-Q, Quarterly Report
May 04 $SQNM up 6.5% today post-earnings. Other biotechs in the green: $CBM $AMRS $RGEN $TTHI $HEB $CBLI $CYCC $PDLI $XOMA $ARQL $TRGT $SPPI $GERN by abubnic
Apr 30 Hemispherx testing whether Ampligen boosts FluMist efficacy
Apr 30 Hemispherx Biopharma announces test of Ampligen with FluMist

Profile

Exchange: AMEX       Sector: Healthcare       Industry: Biotechnology

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Hemispherx Biopharma is down 41.83% over the last year vs S&P 500 Total Return up 2.57%, Sinovac Biotech down 50.41%, and Novavax down 43.97%.

  • HEB Total Returns
  • ^SPXTR Total Returns
  • SVA Total Returns
  • NVAX Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring HEB

Did Hemispherx Biopharma make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

HEB Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
HEB 0.27 -0.00 -0.99% 36.67M
HDSN 3.85 +0.16 +4.34% 87.75M
HCN 55.22 -0.41 -0.74% 11.66B
HBOS 12.35 +0.00 +0.00%
HBAN 6.46 -0.03 -0.46% 5.619B
HAP 32.21 -0.28 -0.86%
HALL 7.28 +0.00 +0.00% 139.25M
HA 5.68 +0.00 +0.00% 272.93M
GXP 19.97 -0.01 -0.05% 2.720B
GSOL 5.45 +0.15 +2.83% 170.24M
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close